Inhaled Levodopa (CVT-301) for the Treatment of Parkinson Disease
Glenardi Glenardi, Tutwuri Handayani, Jimmy Barus, Ghea Mangkuliguna
Abstract
Purpose of Review: To investigate the efficacy and safety of CVT-301 in treating motor fluctuation in patients with Parkinson disease (PD). Recent Findings: = 0.05). Summary: CVT-301 had the potential to be an alternative or even a preferred treatment for motor fluctuation in patients with PD.
Topics & Concepts
LevodopaParkinson's diseaseNauseaOdds ratioRating scaleInternal medicineConfidence intervalMedicinePlaceboAdverse effectPhysical therapyAnesthesiaDiseasePsychologyPathologyDevelopmental psychologyAlternative medicineAmyotrophic Lateral Sclerosis ResearchCystic Fibrosis Research AdvancesParkinson's Disease Mechanisms and Treatments